Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

972 studies match

clinicaltrialsPublishedShowing 1–50 of 972 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03837899	Durvalumab and Tremelimumab for Pediatric Malignancies	active not recruiting	Phase 1 / Phase 2	50	AstraZenecaINDUSTRY	7	Sep 29, 2026	clinicaltrials
NCT04958239	A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer	active not recruiting	Phase 1	151	Boehringer IngelheimINDUSTRY	15	Sep 29, 2026